Portfolio company
Deepcure
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Deep MedChem
This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.
Aizen Therapeutics
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
Seismic Therapeutic
The company develops immunology therapies for autoimmune and allergic diseases using machine learning for biologics discovery in the deep-tech sector.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
